Consolidated Portfolio Review Corp »

Merck & Co shares owned by Consolidated Portfolio Review Corp

Quarter-by-quarter ownership of Merck & Co (MRK) shares owned by Consolidated Portfolio Review Corp from 13F filings

Historical chart of Consolidated Portfolio Review Corp investment in Merck & Co

Tip: Access up to 7 years of quarterly data

All positions including Merck & Co held by Consolidated Portfolio Review Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merck & Co by Consolidated Portfolio Review Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $503k 3.8k 131.96
2023-12-31 $420k 3.9k 109.03
2023-09-30 $458k 4.5k 102.94
2023-06-30 $496k 4.3k 115.40
2023-03-31 $465k 4.4k 106.39

More positions owned by Consolidated Portfolio Review Corp

Vanguard Bd Index Fds Intermed Term (BIV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Growth Etf (VUG)
Vanguard World Health Car Etf (VHT)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Equal Weight Us (GSEW)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Vanguard World Consum Stp Etf (VDC)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Amazon (AMZN)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)

View all positions for Consolidated Portfolio Review Corp

Top funds holding Merck & Co

Vanguard Group
Wellington Management Company
Bank of America Corporation
Charles Schwab Investment Management
T. Rowe Price Associates
Norges Bank Investment Management
Jpmorgan Chase & Co
Legal & General Group
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Wells Fargo & Company
Royal Bank of Canada
UBS Group
State Farm Mutual Automobile Insurance Company
Fisher Investments

View all funds holding Merck & Co